𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Uptake and presentation of malignant glioma tumor cell lysates by monocyte-derived dendritic cells

✍ Scribed by Steven De Vleeschouwer; Mohammed Arredouani; Martine Adé; Pascal Cadot; Elke Vermassen; Jan. L. Ceuppens; Stefaan W. Van Gool

Publisher
Springer-Verlag
Year
2004
Tongue
English
Weight
524 KB
Volume
54
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vaccination with tumor cell lysate-pulse
Vaccination with tumor cell lysate-pulsed dendritic cells augments the effect of IFN-β gene therapy for malignant glioma in an experimental mouse intracranial glioma
✍ Ryuta Saito; Masaaki Mizuno; Norimoto Nakahara; Takaya Tsuno; Toshihiro Kumabe; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 372 KB 👁 1 views

## Abstract Interferon‐β (IFN‐β) has been used as an antitumor drug against human glioma, melanoma and medulloblastoma since the 1980s. Recently, we developed a new gene therapy using the __IFN__‐β gene against malignant gliomas and then began clinical trials in 2000. Since stimulation of immune sy

Induction of leukemic-cell-specific cyto
Induction of leukemic-cell-specific cytotoxic T lymphocytes by autologous monocyte-derived dendritic cells presenting leukemic cell antigens
✍ J.-J. Lee; M.-S. Park; J.-S. Park; H.-K. Kang; S.-K. Kim; T.-N. Nguyen Pham; X.- 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB

Leukemic-dendritic cells (leukemic-DCs) have certain limitations, which include difficult generation in 30-40% of patients, and low levels of expression of several key molecules. Therefore, an alternative approach using monocyte-derived DCs pulsed with tumor antigens is required. We investigated the